Dr. Louis H Geeraerts MD Medical Oncologist

Dr. Louis Geeraerts is a medical oncologist in Fargo, North Dakota and is affiliated with Sanford Medical Center Fargo. He received his medical degree from Universite Libre de Bruxelles Faculty of Medicine and has been in practice for 42 years. Dr. Geeraerts accepts several types of health insurance, listed below. He is one of 8 doctors at Sanford Medical Center Fargo who specialize in Medical Oncology.

Are you Dr. Louis Geeraerts? Claim your profile to make edits or add details. Edit Profile

Office Location

See Contact Information

Specialty & Clinical Interests

Medical Oncologist: General Oncology

Hospital Affiliation

Sanford Medical Center Fargo

Education & Medical Training

Winthrop-University Hospital
Residency, Internal Medicine, 1979 - 1981

Winthrop-University Hospital
Residency, Internal Medicine, 1982 - 1983

Jamaica Hospital
Residency, Internal Medicine, 1978 - 1979

Winthrop-University Hospital
Fellowship, Hematology/Oncology, 1983 - 1985

Columbia University College of Physicians & Surgeons
Fellowship, Fellowship in Hematology/Oncology, 1981 - 1982

Universite Libre de Bruxelles Faculty of Medicine
Class of 1972

Certifications & Licensure

American Board of Internal Medicine
Certified in Cardiovascular Disease

American Board of Internal Medicine
Certified in Internal Medicine

American Board of Internal Medicine
Certified in Interventional Cardiology

AZ State Medical License
Active through 2014

CO State Medical License
Active through 2013

Awards, Honors & Recognition

Meaningful Use Stage 1 Certification, Centers for Medicare & Medicaid Services

Elected Member, The American Society for Clinical Investigation

Publications & Presentations

A phase I study of radiation therapy and twice-weekly gemcitabine and cisplatin in patients with locally advanced pancreatic cancer.
Martenson, J.A., Vigliotti, A.G., Pitot, H.C., Geeraerts, L.H., Sargent, D.J., Haddock, M.G., Ghosh, C., Keppen, M.D., Fitch, T.R., Goldberg, R.M.

Controlled trial of megestrol acetate for the treatment of cancer anorexia and cachexia.
Loprinzi, C. L., Ellison, N. M., Schaid, D. J., Krook, J. E., Athmann, L. M., Dose, A. M., Mailliard, J. A., Johnson, P. S., Ebbert, L. P., Geeraerts, L. H.

North Central Cancer Treatment Group (NCCTG) N0432: phase II trial of docetaxel with capecitabine and bevacizumab as first-line chemotherapy for patients with metastatic breast cancer.
Perez, E. A., Hillman, D. W., Dentchev, T., Le-Lindqwister, N. A., Geeraerts, L. H., Fitch, T. R., Liu, H., Graham, D. L., Kahanic, S. P., Gross, H. M., Patel, T. A., Palmieri, F. M., Dueck, A. C.

See all 6 publications

Insurances Accepted

  • Aetna Choice POS II
  • Aetna HMO
  • BCBS Blue Card PPO
  • BCBS Massachusetts Blue Care Elect PPO
  • CIGNA Open Access
  • First Health PPO
  • Great West PPO
  • Humana ChoiceCare Network PPO
  • Multiplan PHCS PPO
  • Multiplan PPO
  • Tufts Health Plan PPO
  • UniCare PPO
  • United Healthcare - Direct Choice Plus POS
  • United Healthcare - Direct Options PPO
Find More Doctors
Doctor Finder

Our Doctor Finder includes most U.S. physicians. Doctors are not ranked, learn more.

Browse Doctors by



Search all Doctors

Profiles by Doximity

Your Message Has Been Submitted

As part of our research on the correction you submitted, you may be contacted at the email address provided.

Sorry, Your Message Could Not Be Submitted

Please try again later, or E-mail your message to doctors@usnews.com and include the Web address (URL) of the page that contains incorrect information.